Approval · Notice of Compliance 2310 · 2001
HAVRIX: Notice of Compliance 2310
Issued June 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2310
- Date
- June 22, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Active immunizing agent against infection by hepatitis a virus
Products in this notice
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 720 UNIT per 1ML
- HEPATITIS A VACCINE, INACTIVATED 1,440 UNIT per 1ML
- HEPATITIS A VACCINE, INACTIVATED 720 UNIT per 0.5ML